
Search
Filter Results
Displaying 41–50 of 630 for “retinal diseases”
-
Feb 10, 2025
Pioneering Delivery Strategies for Blinding Diseases Therapy and Inspiring Women in Science
International Day of Women and Girls in Science is celebrated globally to recognize the critical role women play in science, technology, engineering, and mathematics. To honor this vital day, the Foundation is thrilled to spotlight Dr. Renee Ryals, PhD, a remarkable scientist at the Casey Eye Institute, Oregon Health & Science University.
-
Jun 9, 2023
The Retinal Research Community Mourns the Loss of Retinal Research Pioneer Thierry Léveillard
Dr. Léveillard helped discover and develop a gene-agnostic, cone-preserving therapy for retinitis pigmentosa that’s moving into a clinical trial.
-
Mutations in PRPH2 are a relatively common cause of several inherited retinal degenerations, including: retinitis pigmentosa (RP), pattern macular dystrophies (PMDs), cone-rod dystrophies (CRDs), and central areolar choroidal dystrophy (CACD).
-
Jul 25, 2017
The partnership will help companies and researchers quickly obtain and implement high-quality vectors for their retinal gene-therapy development efforts.
-
Mar 30, 2020
10 Things to Know Before You Fall Victim to a Retinal Stem Cell Scam
An article by David Gamm, MD, PhD, a Foundation-funded researcher at the University of Wisconsin-Madison
-
Jul 29, 2016
Artist with Usher Syndrome Excited to Register on My Retina Tracker to Drive Retinal Research
Artist Dana Simon describes her experience with My Retina Tracker, a free and secure online registry for people with inherited retinal diseases.
-
Jan 9, 2023
Retinal Research Community Loses Beloved Pioneer Sam Jacobson
His many contributions included pivotal work that led to LUXTURNA
-
Oct 10, 2022
Recap of Retinal Disease News from the 2022 Meeting of the American Academy of Ophthalmology
Reports on emerging therapies for dry age-related macular degeneration (geographic atrophy), Stargardt disease, and X-linked retinitis pigmentosa are included
-
Nov 2, 2018
Foundation Invests $2.5 Million in Search for Elusive Retinal Disease Genes and Mutations
Since 1989 genetic researchers, many funded by the Foundation, have identified approximately 270 genes linked to IRDs. In most cases, defects in a single gene can cause a retinal disease and vision loss.
-
Apr 16, 2018
Retinal Patch Performs Promisingly in Clinical Trial for Dry AMD Patients
Regenerative Patch Technologies, a company developing stem-cell-derived treatments for people with retinal diseases, has reported encouraging results for the first five patients with advanced, dry age-related macular degeneration (AMD) participating in a Phase I/IIa clinical trial for its therapy – a patch comprised of a layer of retinal pigment epithelial (RPE) cells on a synthetic scaffold.